Changzhou Qianhong Biopharma Co., Ltd.

Changzhou Qianhong Biopharma Co., Ltd. is a prominent manufacturer and distributor in the pharmaceutical manufacturing sector, specializing in polysaccharide and protease drugs. Established as a national high-tech enterprise, it has been recognized for its commitment to drug quality integrity. The company was listed on the Shenzhen Stock Exchange in 2011 and operates through four holding subsidiaries, enhancing its capabilities in biopharmaceutical development and distribution. The company’s primary product lines include kallidinogenase series, heparin sodium, low molecular weight heparin, compound digestive enzyme preparations, and asparaginase series. It is one of the few manufacturers in China that covers the entire heparin industry chain. Changzhou Qianhong has developed a robust marketing network, with products distributed across more than twenty provinces in China and exported to international markets including Europe, the USA, and Japan. The company also emphasizes innovation, with significant advancements in recombinant protein drugs and targeted anti-tumor therapies, supported by a strong research and development platform.

1. Industry advantages The biopharmaceutical industry has become an important sector in China's national economy. Biopharmaceutical products have the characteristics of targeting and safety, as well as high technical barriers, and have become an important indicator of a country's modern biotechnology development level. The biopharmaceutical industry is one of the fastest-growing, most dynamic, and technologically advanced fields in the pharmaceutical industry. The "Made in China 2025" issued by the State Council includes biomedicine and high-performance medical devices as one of the top ten key areas. The company specializes in the research and development, production, and sales of biopharmaceuticals, ranking among the top in the biopharmaceutical industry, with strong competitiveness and high visibility. 2. Product competitiveness advantages The company is a leading producer and operator of protease and polysaccharide drugs, and is currently one of the few drug manufacturers in China that covers the entire heparin industry chain. The enzyme preparations mainly include pancreatic kininogenase series, compound digestive enzyme capsule II, and asparaginase series; The main varieties of polysaccharides are heparin sodium and small molecule heparin series, with a rich product line, reasonable product structure, and obvious comprehensive competitive advantages. They can effectively resist market risks and ensure sustained performance growth. 3. Advantages of Innovation Platform The company vigorously promotes technological innovation, introduces high-level talents from overseas to establish two joint venture research institutes, and sets up offshore drug research and development centers abroad. Based on this, the company establishes the "Changzhou Qianhong International Biomedical Innovation Drug Incubation Base". The company has made significant progress in the fields of biopharmaceutical innovation, such as gene recombination and targeted anti-cancer drugs. As of the end of the reporting period, the company has three innovative drugs entering phase II clinical trials, one innovative drug is about to enter phase II clinical trials, and multiple innovative drugs are in various stages of clinical research, which will provide strong core competitiveness for the company's future development. At the same time, the innovative drug industrialization project built by the company has been successfully completed and has been put into the production of clinical research samples for new drugs, laying a solid foundation for the transformation of innovative drug achievements under research. 4. Advantages of Technical Quality Management The company is a national high-tech enterprise that has developed core technologies such as modern molecular membrane ultrafiltration, molecular affinity chromatography, molecular structure chelation, virus inactivation, and integrated them into large-scale production of biochemical enzyme drugs and polysaccharide drugs. It has established an industrial production technology platform. The company has nearly 80000 square meters of high-level pharmaceutical production workshops and quality testing centers that comply with European and American GMP standards. It has a high-quality professional technical quality management team, a relatively complete production technology quality management system, and has been awarded the title of National, Provincial, and Municipal Drug Quality Integrity Demonstration Enterprise for many years. The internal control quality standards of multiple key products of the company have been upgraded to national drug quality standards; The main drugs exported have passed the GMP certification of the US FDA, EU COS, Germany, Japan, Australia and other countries. They also participate in the international standardization work of the US USP heparin sodium raw material, which has a certain competitive advantage among domestic and foreign peers. 5. Advantages of Talent Team Since its listing, the company (including its subsidiaries) has introduced a large number of young and talented individuals with high levels of education and specialization from both domestic and foreign sources. Currently, it has nearly 20 PhDs and over 80 masters, with more than 89% of the company's employees having a college degree or above. These individuals are widely distributed in the company's marketing, technology, and management teams, forming a stable talent pool system and laying a solid talent foundation for the company's future strategic development and business management needs. 6. Advantages of Marketing Model After years of accumulation, the company has established a diversified business model for domestic formulation sales, with self operated sales as the main body, investment promotion, and channels advancing simultaneously; Through technology and trade cooperation, multiple stable distribution networks for active pharmaceutical ingredients and formulations have been established in countries such as Europe, America, and Japan in foreign markets; It demonstrates the company's professional marketing team, diversified product structure and sales market competitiveness and advantages among peers. 7. Advantages of Qianhong Culture The company has established a modern enterprise management and governance system and standardized operating mechanism, and the operation and development of the enterprise continue to be stable; Qianhong has formed a unique culture of "integrity, pragmatism, and harmony", constructed a systematic corporate culture system, firmly established the awareness of "innovative development" in the hearts of cadres and employees, and recognized the values of "common development, co creation of prosperity". "I am proud of Qianhong, and Qianhong is proud of me" has become a trend, fully demonstrating the cultural connotation advantages of the company's sustainable and healthy development. The company adheres to the leadership of party building and cultural innovation, organically integrates party building work with daily operations, enhances the core competitiveness of the enterprise, and takes the Changzhou non-public enterprise party building work exhibition center as the battlefield to create a Qianhong characteristic party building brand. With Qianhong characteristic party building work as the starting point, the company strengthens the construction of its corporate culture management system.